Introduction to Targeted Therapies: Monoclonal Antibodies

TKG PACT Executive Briefings - 3-Minute Market Insights

内容由The Kinetix Group, Powered by Petauri, The Kinetix Group, and Powered by Petauri提供。所有播客内容（包括剧集、图形和播客描述）均由 The Kinetix Group, Powered by Petauri, The Kinetix Group, and Powered by Petauri 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。

3M ago 3:32

MP3•单集首页

Send us a text

Introduction to Targeted Therapies: Monoclonal Antibodies

Targeted Therapy is the foundation of Precision Medicine. Targeted therapy is a type of personalized treatment that targets specific proteins that control how cells grow, divide, and spread.

Antibodies are produced naturally by our body and help the immune system recognize cells that cause disease, such as bacteria and viruses, and mark them for destruction. Antibodies can be engineered in the laboratory to find and attach themselves to specific targets, called antigens, found on cancer cells. They are made to recognize and bind only to a very specific antigen target.

This week's episode highlights three important terms you may be hearing: Antibody-Drug Conjugates, Monoclonal Antibodies, and Bispecific Antibodies.
You can download the full Executive Briefing at: https://tkgpact.com/executive-briefings/

Or, feel free to email us at Insights@thekinetixgroup.com

59集单集

#Fitness #Medicine #The Kinetix Group #Healthcare #Pharma #Voice #Triple Aim #Biotech #Health Management #Science #Alternative Health #Biology #Insight